Liver Injury/Regeneration News

In a new study published in The American Journal of Gastroenterology, researchers found persistent liver injury was prevalent over time among a majority of patients with drug-induced liver injury.

Isonicotinic acid hydrazide-associated hepatotoxicity is a leading cause of drug-induced liver injury in the United States, and a majority of cases found in patients with latent tuberculosis are underreported to the CDC, according to published findings.

Researchers combined results from static and dynamic scoring systems to create a joint-effect model that accurately predicted survival of patients with alcoholic hepatitis, according to study data.

In The Rotterdam Study, researchers found that liver stiffness is strongly associated with steatosis and diabetes, indicating that as the prevalence of steatosis and diabetes increases, liver fibrosis could become a major public health problem, according to published findings.

Kidney function, more specifically the kidney injury molecule 1, was found to be a predictor of outcomes in patients with acetaminophen-induced liver injury, according to study data.

A single dose of cefazolin, a type of cephalosporin, could lead to drug-induced liver injury, with other cephalosporins linked to even more severe cases, according to study data published in Clinical Gastroenterology and Hepatology.

Researchers in Germany found mutations present in neuroblastoma amplified sequence that helped to identify the origin of acute liver failure in children and recommend the method be performed in any patient with the event, particularly those affected by febrile infection.

In patients with acute-on-liver failure enrolled in the CANONIC study, researchers found that following the course of the disease after diagnosis could be a useful tool in determining the need for liver transplant, according to study data.

Researchers from Boston University and Boston Medical Center have developed a patient-derived induced pluripotent stem cell model that could be used to better understand liver and lung disease, according to study data published in Stem Cell Reports.

The FDA is advising consumers to stop using a dietary supplement due to its severe adverse events, including serious liver injury, according to a press release from the FDA.